"The nationally accredited Delbert Day Cancer Institute (DDCI) at Phelps Health provides all cancer care services under one roof for convenience and continuity of care for patients and their families."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
117
SWOG Cancer Research Network
36
Alliance for Clinical Trials in Oncology
32
ECOG-ACRIN Cancer Research Group
19
NRG Oncology
16
Gynecologic Oncology Group
7
Wake Forest University Health Sciences
6
GOG Foundation
4
Radiation Therapy Oncology Group
2
Eastern Cooperative Oncology Group
1
National Heart, Lung, and Blood Institute (NHLBI)
1
Clinical Trials at Delbert Day Cancer Institute at PCRMC
During the past decade, Delbert Day Cancer Institute at PCRMC conducted 158 clinical trials. In the 10-year time frame, 158 clinical trials started and 83 clinical trials were completed, i.e. on
average, 52.5% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 54 clinical trials were completed. i.e. 108%
of trials that started reached the finish line.
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Delbert Day Cancer Institute at PCRMC" #1 sponsor was "National Cancer Institute (NCI)" with 117 trials, followed by "SWOG Cancer Research Network" with 36 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored and "NRG Oncology"
with 19 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Delbert Day Cancer Institute at PCRMC"
#1 collaborator was "National Cancer Institute (NCI)" with 123 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Delbert Day Cancer Institute at PCRMC
According to Clinical.Site data, the most researched conditions in "Delbert Day Cancer Institute at PCRMC" are
"Invasive Breast Carcinoma" (11 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Lung Cancer AJCC v8" (9 trials). Many other conditions were trialed in "Delbert Day Cancer Institute at PCRMC" in a lesser frequency.
Clinical Trials Intervention Types at Delbert Day Cancer Institute at PCRMC
Most popular intervention types in "Delbert Day Cancer Institute at PCRMC" are "Drug" (189 trials), "Other" (153 trials), "Biological" (99 trials), "Procedure" (68 trials) and "Radiation" (47 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (77 trials), "Quality-of-Life Assessment" (60 trials), "Questionnaire Administration" (40 trials), "Biospecimen Collection" (35 trials) and "Cisplatin" (33 trials). Other intervention names were less common.
Clinical Trials Genders at Delbert Day Cancer Institute at PCRMC
The vast majority of trials in "Delbert Day Cancer Institute at PCRMC" are
189 trials for "All" genders, 41 trials for "Female" genders and 11 trials for "Male" genders.
Clinical Trials Status at Delbert Day Cancer Institute at PCRMC
Currently, there are NaN active trials in "Delbert Day Cancer Institute at PCRMC".
undefined are not yet recruiting,
80 are recruiting,
108 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 33 completed trials in Delbert Day Cancer Institute at PCRMC,
9 suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Delbert Day Cancer Institute at PCRMC, 7 "Phase 1"
clinical trials were conducted, 126 "Phase 2" clinical
trials and 115 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".